DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Pfizer (NYSE: PFE)

company name or ticker
Company Photos
(Click to zoom)

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

How the Rising Dollar May Impact Your Portfolio - Stocks in the News

HCP Boasts Of 29 Years Of Dividend Increases

HCP Boosts Of 29 Years Of Dividend Increases

The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs

Why Merck (MRK) Stock Is Gaining Today

3 Stocks Reiterated As A Buy: PFE, VZ, C

Should Gilead Sciences, inc. Fear This New Competitor Drug?

GlaxoSmithKline and Pfizer's ViiV have won approval for a new HIV therapy that may work better than Gilead's Atripla.

Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen

Late-Cycle Nirvana: Moaty Dividends on the Cheap